Market Research

Global IV Dressing Market Size, Share & Trends Analysis Report By Type (Transparent, and Translucent), By End-use (Hospitals, Clinics, and Others), By Regional Outlook and Forecast, 2024 - 2031

Best Price Guarantee Length Publisher Published Date SKU
from $3,600 227 Pages Knowledge Based Value (KBV) Research April, 2024 KBV18746396
Best Price Guarantee
Price from $3,600
Length 227 Pages
Publisher Knowledge Based Value (KBV) Research
Published Date April, 2024
SKU KBV18746396

Global IV Dressing Market Size, Share & Trends Analysis Report By Type (Transparent, and Translucent), By End-use (Hospitals, Clinics, and Others), By Regional Outlook and Forecast, 2024 - 2031


The Global IV Dressing Market size is expected to reach $1.3 Billion by 2031, rising at a market growth of 5.9% CAGR during the forecast period. In the year 2023, the market attained a volume of 44,950.9 thousand units, experiencing a growth of 17.3% (2020-2023).

In 2023, the Asia Pacific region acquired a significant revenue share in the IV dressing market. The Asia Pacific region is seeing an upsurge in the frequency of chronic diseases like diabetes, cardiovascular disease, and cancer, owing primarily to urbanization, sedentary lifestyles, and changing dietary patterns. Therefore, the region is expected to generate 26.55% revenue share by 2031. Also, China would consume 6,159.7 thousand units of these dressings by 2031. The Asia Pacific region's economic expansion is causing governments and private sector organizations to invest more in enhancing healthcare infrastructure and broadening access to healthcare services, increasing healthcare spending.

Ambulatory care centers provide a wide range of medical treatments and procedures on an outpatient basis. Many of these procedures, such as infusion therapies, diagnostic tests, and minor surgeries, require IV access for medication administration. Therefore, the market is expanding significantly due to the expansion of ambulatory care centers. Additionally, Cancer patients frequently undergo chemotherapy or radiation therapy, which may require IV administration of chemotherapy drugs or supportive medications. Furthermore, cancer patients may require IV fluids or blood products to manage side effects such as dehydration or anemia. Thus, because of the growing prevalence of chronic diseases, the market is anticipated to increase significantly.

Moreover, The IV dressing market, like many other sectors of the healthcare industry, experienced disruptions in the supply chain due to lockdowns, travel restrictions, and logistical challenges caused by the pandemic. Manufacturers faced difficulties in sourcing raw materials, production delays, and distribution bottlenecks, leading to shortages of IV dressings in some regions. Also, The COVID-19 pandemic increased demand for IV therapy, notably in treating critically ill COVID-19 patients. IV therapy is crucial for administering fluids, medications, and other life-saving treatments to patients experiencing respiratory distress, dehydration, or complications from the virus. Thus, the COVID-19 pandemic had a moderate effect on the IV dressing market.

However, supply chain disruptions, like natural disasters, transportation delays, or manufacturing issues, can lead to shortages or stockouts. Healthcare institutions rely on a consistent supply of dressings to support patient care and treatment, and supply interruptions can disrupt clinical workflows, cause delays in procedures, and compromise patient safety. Thus, supply chain disruptions can slow down the growth of the market.

By Type Analysis

By type, the market is categorized as transparent and translucent. The translucent segment covered 25.23% considerable revenue share in the market in 2023 and in terms of volume the translucent segment consumes 8,418.6 thousand units in 2023. Translucent balance transparency and opacity, providing healthcare providers a partially clear view of the insertion site while offering some opacity for privacy and light protection. This versatility makes translucent dressings suitable for various clinical applications, driving their adoption across various healthcare settings. Translucent dressings are less noticeable on the skin than opaque dressings, providing a more aesthetically pleasing appearance for patients. The semi-transparent nature of translucent dressings allows for discreet monitoring of the insertion site while maintaining patient privacy and dignity, enhancing the overall patient experience.

By End-use Analysis

Based on end-use, the market is classified into hospitals, clinics, and others. The clinics segment acquired 32.13% revenue share in the market in 2023. In terms of volume, the clinics segment registered 13,373.8 thousand units in 2023. Clinics perform a wide range of outpatient procedures that require IV access for medication administration, fluid therapy, and diagnostic testing. As the trend towards outpatient care continues to grow, driven by convenience, cost-effectiveness, and advancements in medical technology, the demand for dressings in clinics rises accordingly.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the North America region led the market by generating 40.93% revenue share. North America has a significant population affected by chronic diseases like diabetes, cardiovascular diseases, and cancer. North America boasts advanced healthcare infrastructure with well-established hospitals, clinics, and ambulatory care centers with state-of-the-art facilities and technologies. The aging population in North America contributes to the demand for healthcare services, including IV therapy.

List of Key Companies Profiled
  • 3M Company
  • Cardinal Health, Inc.
  • Smith & Nephew PLC
  • McKesson Corporation
  • Covalon Technologies Ltd.
  • Becton, Dickinson, and Company
  • Molnlycke Health Care AB
  • DermaRite Industries, LLC
  • Dynarex Corporation
  • Essity AB (BSN medical)
Global IV Dressing Market Report Segmentation

By Type (Volume, Thousand Units, USD Billion, 2020-2031)
  • Transparent
  • Translucent
By End-use (Volume, Thousand Units, USD Billion, 2020-2031)
  • Hospitals
  • Clinics
  • Others
By Geography (Volume, Thousand Units, USD Billion, 2020-2031)
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global IV Dressing Market, by Type
1.4.2 Global IV Dressing Market, by End-use
1.4.3 Global IV Dressing Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Global IV Dressing Market by Type
4.1 Global Transparent Market by Region
4.2 Global Translucent Market by Region
Chapter 5. Global IV Dressing Market by End-use
5.1 Global Hospitals Market by Region
5.2 Global Clinics Market by Region
5.3 Global Others Market by Region
Chapter 6. Global IV Dressing Market by Region
6.1 North America IV Dressing Market
6.1.1 North America IV Dressing Market by Type
6.1.1.1 North America Transparent Market by Region
6.1.1.2 North America Translucent Market by Region
6.1.2 North America IV Dressing Market by End-use
6.1.2.1 North America Hospitals Market by Country
6.1.2.2 North America Clinics Market by Country
6.1.2.3 North America Others Market by Country
6.1.3 North America IV Dressing Market by Country
6.1.3.1 US IV Dressing Market
6.1.3.1.1 US IV Dressing Market by Type
6.1.3.1.2 US IV Dressing Market by End-use
6.1.3.2 Canada IV Dressing Market
6.1.3.2.1 Canada IV Dressing Market by Type
6.1.3.2.2 Canada IV Dressing Market by End-use
6.1.3.3 Mexico IV Dressing Market
6.1.3.3.1 Mexico IV Dressing Market by Type
6.1.3.3.2 Mexico IV Dressing Market by End-use
6.1.3.4 Rest of North America IV Dressing Market
6.1.3.4.1 Rest of North America IV Dressing Market by Type
6.1.3.4.2 Rest of North America IV Dressing Market by End-use
6.2 Europe IV Dressing Market
6.2.1 Europe IV Dressing Market by Type
6.2.1.1 Europe Transparent Market by Country
6.2.1.2 Europe Translucent Market by Country
6.2.2 Europe IV Dressing Market by End-use
6.2.2.1 Europe Hospitals Market by Country
6.2.2.2 Europe Clinics Market by Country
6.2.2.3 Europe Others Market by Country
6.2.3 Europe IV Dressing Market by Country
6.2.3.1 Germany IV Dressing Market
6.2.3.1.1 Germany IV Dressing Market by Type
6.2.3.1.2 Germany IV Dressing Market by End-use
6.2.3.2 UK IV Dressing Market
6.2.3.2.1 UK IV Dressing Market by Type
6.2.3.2.2 UK IV Dressing Market by End-use
6.2.3.3 France IV Dressing Market
6.2.3.3.1 France IV Dressing Market by Type
6.2.3.3.2 France IV Dressing Market by End-use
6.2.3.4 Russia IV Dressing Market
6.2.3.4.1 Russia IV Dressing Market by Type
6.2.3.4.2 Russia IV Dressing Market by End-use
6.2.3.5 Spain IV Dressing Market
6.2.3.5.1 Spain IV Dressing Market by Type
6.2.3.5.2 Spain IV Dressing Market by End-use
6.2.3.6 Italy IV Dressing Market
6.2.3.6.1 Italy IV Dressing Market by Type
6.2.3.6.2 Italy IV Dressing Market by End-use
6.2.3.7 Rest of Europe IV Dressing Market
6.2.3.7.1 Rest of Europe IV Dressing Market by Type
6.2.3.7.2 Rest of Europe IV Dressing Market by End-use
6.3 Asia Pacific IV Dressing Market
6.3.1 Asia Pacific IV Dressing Market by Type
6.3.1.1 Asia Pacific Transparent Market by Country
6.3.1.2 Asia Pacific Translucent Market by Country
6.3.2 Asia Pacific IV Dressing Market by End-use
6.3.2.1 Asia Pacific Hospitals Market by Country
6.3.2.2 Asia Pacific Clinics Market by Country
6.3.2.3 Asia Pacific Others Market by Country
6.3.3 Asia Pacific IV Dressing Market by Country
6.3.3.1 China IV Dressing Market
6.3.3.1.1 China IV Dressing Market by Type
6.3.3.1.2 China IV Dressing Market by End-use
6.3.3.2 Japan IV Dressing Market
6.3.3.2.1 Japan IV Dressing Market by Type
6.3.3.2.2 Japan IV Dressing Market by End-use
6.3.3.3 India IV Dressing Market
6.3.3.3.1 India IV Dressing Market by Type
6.3.3.3.2 India IV Dressing Market by End-use
6.3.3.4 South Korea IV Dressing Market
6.3.3.4.1 South Korea IV Dressing Market by Type
6.3.3.4.2 South Korea IV Dressing Market by End-use
6.3.3.5 Singapore IV Dressing Market
6.3.3.5.1 Singapore IV Dressing Market by Type
6.3.3.5.2 Singapore IV Dressing Market by End-use
6.3.3.6 Malaysia IV Dressing Market
6.3.3.6.1 Malaysia IV Dressing Market by Type
6.3.3.6.2 Malaysia IV Dressing Market by End-use
6.3.3.7 Rest of Asia Pacific IV Dressing Market
6.3.3.7.1 Rest of Asia Pacific IV Dressing Market by Type
6.3.3.7.2 Rest of Asia Pacific IV Dressing Market by End-use
6.4 LAMEA IV Dressing Market
6.4.1 LAMEA IV Dressing Market by Type
6.4.1.1 LAMEA Transparent Market by Country
6.4.1.2 LAMEA Translucent Market by Country
6.4.2 LAMEA IV Dressing Market by End-use
6.4.2.1 LAMEA Hospitals Market by Country
6.4.2.2 LAMEA Clinics Market by Country
6.4.2.3 LAMEA Others Market by Country
6.4.3 LAMEA IV Dressing Market by Country
6.4.3.1 Brazil IV Dressing Market
6.4.3.1.1 Brazil IV Dressing Market by Type
6.4.3.1.2 Brazil IV Dressing Market by End-use
6.4.3.2 Argentina IV Dressing Market
6.4.3.2.1 Argentina IV Dressing Market by Type
6.4.3.2.2 Argentina IV Dressing Market by End-use
6.4.3.3 UAE IV Dressing Market
6.4.3.3.1 UAE IV Dressing Market by Type
6.4.3.3.2 UAE IV Dressing Market by End-use
6.4.3.4 Saudi Arabia IV Dressing Market
6.4.3.4.1 Saudi Arabia IV Dressing Market by Type
6.4.3.4.2 Saudi Arabia IV Dressing Market by End-use
6.4.3.5 South Africa IV Dressing Market
6.4.3.5.1 South Africa IV Dressing Market by Type
6.4.3.5.2 South Africa IV Dressing Market by End-use
6.4.3.6 Nigeria IV Dressing Market
6.4.3.6.1 Nigeria IV Dressing Market by Type
6.4.3.6.2 Nigeria IV Dressing Market by End-use
6.4.3.7 Rest of LAMEA IV Dressing Market
6.4.3.7.1 Rest of LAMEA IV Dressing Market by Type
6.4.3.7.2 Rest of LAMEA IV Dressing Market by End-use
Chapter 7. Company Profiles
7.1 3M Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Trials and Approvals:
7.1.6 SWOT Analysis
7.2 Cardinal Health, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 SWOT Analysis
7.3 Smith & Nephew PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional and Segmental Analysis
7.3.4 Research & Development Expense
7.3.5 SWOT Analysis
7.4 McKesson Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Covalon Technologies Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Research & Development Expenses
7.6 Becton, Dickinson, and Company
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 SWOT Analysis
7.7 Molnlycke Health Care AB
7.7.1 Company Overview
7.7.2 SWOT Analysis
7.8 DermaRite Industries, LLC
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Dynarex Corporation
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. Essity AB (BSN medical)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 SWOT Analysis
Chapter 8. Winning Imperatives of IV Dressing Market

$3,600
$4,320
$6,048

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings